文献速递耳科与耳神经小儿耳鼻咽喉

儿童耳铁蛋白相关听神经病谱系障碍的基因治疗

Gene Therapy for Infants and Children With Otoferlin-Related Auditory Neuropathy Spectrum Disorder.
PubMed 文献 · Ear Hear · 2026-04-14

本文综述了耳铁蛋白相关听神经病谱系障碍的基因治疗进展。文章指出基因治疗已成为首个实现治愈听力损失这一此前不可能任务的疗法,目前应用范围局限于耳铁蛋白相关听神经病,但早期结果令人鼓舞。文章强调基因检测是识别潜在候选者的关键,并呼吁扩大基因检测可及性及加深对研究不足人群中致病变异的理解。

要点

  • 基因治疗是首个实现治愈听力损失的疗法,目前仅适用于耳铁蛋白相关听神经病。
  • 基因检测是识别耳铁蛋白基因治疗潜在候选者的关键。
  • 需扩大基因检测可及性并加深对研究不足人群致病变异的理解。

核心结论

  • 基因治疗已成为首个实现治愈听力损失这一此前不可能任务的疗法,目前应用范围局限于耳铁蛋白相关听神经病,早期结果令人鼓舞。

研究设计与样本

  • 本文为综述,聚焦耳铁蛋白相关听神经病谱系障碍的基因治疗进展。

主要发现

  • 部分首批接受耳铁蛋白基因治疗的儿童取得了巨大成功,激发了新研究时代。
  • 耳铁蛋白基因治疗的早期成功能否在其他形式的遗传性听力损失中复制仍是未解问题。

关键数值与推荐

  • 基因检测是开启这些重要新型疗法机会的关键。
  • 扩大基因检测可及性和加深对研究不足人群中致病变异的理解是重要目标。

临床怎么用

  • 临床应通过基因检测识别耳铁蛋白相关听神经病的潜在候选者,并将该疗法整合入治疗工具箱。

局限性

  • 当前基因治疗应用范围狭窄,仅限于耳铁蛋白相关听神经病。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

After decades of research focused on hair cell regeneration and the use of stem cells to regenerate the sensory epithelium, gene therapy has now emerged as the first therapy to accomplish the previously impossible task of curing hearing loss. While the current application of gene therapy is narrow, limited to otoferlin-related auditory neuropathy, early results are promising, and the tremendous success of some of the very first children receiving otoferlin gene therapy inspires an era of new research. How to identify potential candidates for otoferlin gene therapy and how to integrate this therapy into our toolbox will be an important area of development for our profession. Genetic testing is the key that opens opportunities for these important novel therapies. Expanding both access to genetic testing and our understanding of pathogenic variants in understudied populations will be important goals to provide hearing broadly for those children who can benefit from these groundbreaking therapies. Whether the early success of otoferlin gene therapy will be replicated in other forms of genetic hearing loss remains an open question.

来源:Ear Hear,查看原文。版权归原作者所有。

引用

  1. Lesperance MM, Devare J, McCreery RW, et al. Gene Therapy for Infants and Children With Otoferlin-Related Auditory Neuropathy Spectrum Disorder. Ear Hear. 2026. PMID: 41979424. doi:10.1097/AUD.0000000000001773

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。